Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 93 entries
View as:

Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding

Phase: N/A Priority: Normal
NCT ID: NCT00158509 Org: User:
Start: 08/31/04 End: 07/31/05 Due: 07/31/06

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00196586 Org: User:
Start: 04/30/03 End: 11/30/06 Due: 11/30/07

Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders

Phase: N/A Priority: Normal
NCT ID: NCT01226446 Org: User:
Start: 11/30/10 End: 01/31/13 Due: 01/31/14

Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration

Phase: N/A Priority: Normal
NCT ID: NCT00944541 Org: User:
Start: 09/30/09 End: 01/31/11 Due: 01/31/12

Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00196638 Org: User:
Start: 05/31/02 End: 03/31/06 Due: 03/31/07

Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)

Phase: N/A Priority: Normal
NCT ID: NCT00158483 Org: User:
Start: 05/31/03 End: 10/31/05 Due: 10/31/06

Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices

Phase: N/A Priority: Normal
NCT ID: NCT00657397 Org: User:
Start: 01/31/09 End: 12/31/11 Due: 12/31/12

Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00391638 Org: User:
Start: 01/31/07 End: 10/31/12 Due: 10/31/13

Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries

Phase: N/A Priority: Normal
NCT ID: NCT01494961 Org: User:
Start: 02/28/09 End: 10/31/11 Due: 10/31/12

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

Phase: N/A Priority: Normal
NCT ID: NCT00120185 Org: User:
Start: 12/31/03 End: 11/30/06 Due: 11/30/07

Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)

Phase: N/A Priority: Normal
NCT ID: NCT00495651 Org: User:
Start: 03/31/08 End: 01/31/15 Due: 01/31/16

Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection

Phase: N/A Priority: Normal
NCT ID: NCT01065207 Org: User:
Start: 03/31/09 End: 03/31/12 Due: 03/31/13

Lenalidomide in Kaposi Disease Associated With HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01282047 Org: User:
Start: 10/31/11 End: 02/28/14 Due: 02/28/15

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

Phase: N/A Priority: Normal
NCT ID: NCT00122655 Org: User:
Start: 01/31/01 End: 06/30/05 Due: 06/30/06

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

Phase: N/A Priority: Normal
NCT ID: NCT00495326 Org: User:
Start: 12/31/07 End: 04/30/11 Due: 04/30/12

Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)

Phase: N/A Priority: Normal
NCT ID: NCT00573001 Org: User:
Start: 07/31/08 End: 12/31/11 Due: 12/31/12

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00122668 Org: User:
Start: 11/30/03 End: 07/31/05 Due: 07/31/06

Long-Term Supervised Treatment Interruption in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00118677 Org: User:
Start: 02/28/03 End: 05/31/07 Due: 05/31/08

Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

Phase: N/A Priority: Normal
NCT ID: NCT00148850 Org: User:
Start: 02/28/03 End: 10/31/04 Due: 10/31/05

Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)

Phase: N/A Priority: Normal
NCT ID: NCT00301561 Org: User:
Start: 05/31/06 End: 10/31/10 Due: 10/31/11

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00946595 Org: User:
Start: 11/30/09 End: 01/31/14 Due: 01/31/15

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Phase: N/A Priority: Normal
NCT ID: NCT00421551 Org: User:
Start: 03/31/07 End: 02/28/11 Due: 02/28/12

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00490074 Org: User:
Start: 07/31/07 End: 10/31/09 Due: 10/31/10

Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV

Phase: N/A Priority: Normal
NCT ID: NCT03671291 Org: User:
Start: 04/03/19 End: 10/03/21 Due: 10/03/22

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

Phase: N/A Priority: Normal
NCT ID: NCT00115609 Org: User:
Start: 01/31/06 End: 11/30/09 Due: 11/30/10